Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub Redazione 10 Dicembre 2020 ...
Direct‐acting antiviral agents in lymphoproliferative disorders: more complex than expected Redazione 10 Dicembre 2020 ...
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma Redazione 3 Dicembre 2020 ...
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 Redazione 3 Dicembre 2020 ...
Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML Redazione 3 Dicembre 2020 ...
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance Redazione 3 Dicembre 2020 ...
Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review Redazione 26 Novembre 2020 ...
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study Redazione 26 Novembre 2020 ...